Search

Anthony H Nguyen

Examiner (ID: 17425)

Most Active Art Unit
2854
Art Unit(s)
3307, 2854, 2853
Total Applications
2014
Issued Applications
1600
Pending Applications
48
Abandoned Applications
337

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9306081 [patent_doc_number] => 20140044755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'RNAi PHARMACEUTICAL COMPOSITION FOR SUPPRESSING EXPRESSION OF KRAS GENE' [patent_app_type] => utility [patent_app_number] => 13/943038 [patent_app_country] => US [patent_app_date] => 2013-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22734 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13943038 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/943038
RNAi pharmaceutical composition for suppressing expression of KRAS gene Jul 15, 2013 Issued
Array ( [id] => 9108349 [patent_doc_number] => 20130281481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'SUBLINGUAL AND BUCCAL FILM COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/923749 [patent_app_country] => US [patent_app_date] => 2013-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11985 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13923749 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/923749
SUBLINGUAL AND BUCCAL FILM COMPOSITIONS Jun 20, 2013 Abandoned
Array ( [id] => 9517827 [patent_doc_number] => 20140154319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE' [patent_app_type] => utility [patent_app_number] => 13/924291 [patent_app_country] => US [patent_app_date] => 2013-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11486 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13924291 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/924291
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE Jun 20, 2013 Abandoned
Array ( [id] => 10262815 [patent_doc_number] => 20150147812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-28 [patent_title] => 'CARRIER FOR GENE INTRODUCTION USE, GENE INTRODUCTION AGENT, METHODS FOR PRODUCING SAID CARRIER AND SAID GENE INTRODUCTION AGENT, AND METHOD FOR INTRODUCING GENE INTO CELL' [patent_app_type] => utility [patent_app_number] => 14/403957 [patent_app_country] => US [patent_app_date] => 2013-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9913 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403957 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/403957
CARRIER FOR GENE INTRODUCTION USE, GENE INTRODUCTION AGENT, METHODS FOR PRODUCING SAID CARRIER AND SAID GENE INTRODUCTION AGENT, AND METHOD FOR INTRODUCING GENE INTO CELL May 29, 2013 Abandoned
Array ( [id] => 9197756 [patent_doc_number] => 20130337071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'RADIOFREQUENCY-INDUCED SYNCHRONIZATION OF IN SITU HYPERTHERMIA AND CHEMOTHERAPY VIA MAGNETIC-NANOCONJUGATES' [patent_app_type] => utility [patent_app_number] => 13/905177 [patent_app_country] => US [patent_app_date] => 2013-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6153 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13905177 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/905177
Radiofrequency-induced synchronization of in situ hyperthermia and chemotherapy via magnetic-nanoconjugates May 29, 2013 Issued
Array ( [id] => 10247397 [patent_doc_number] => 20150132393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-14 [patent_title] => 'NANOSTRUCTURE COATED WITH A TWIST-STRAINED DOUBLE-STRANDED CIRCULAR DEOXYRIBONUCLEIC|ACID (DNA), METHOD FOR MAKING AND USE' [patent_app_type] => utility [patent_app_number] => 14/397834 [patent_app_country] => US [patent_app_date] => 2013-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9109 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14397834 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/397834
NANOSTRUCTURE COATED WITH A TWIST-STRAINED DOUBLE-STRANDED CIRCULAR DEOXYRIBONUCLEIC|ACID (DNA), METHOD FOR MAKING AND USE Apr 25, 2013 Abandoned
Array ( [id] => 9771256 [patent_doc_number] => 20140294919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'VACCINES' [patent_app_type] => utility [patent_app_number] => 13/870762 [patent_app_country] => US [patent_app_date] => 2013-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9689 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13870762 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/870762
VACCINES Apr 24, 2013 Abandoned
Array ( [id] => 9262067 [patent_doc_number] => 20130343996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'GRAPHITE-COATED MAGNETIC NANOPARTICLES' [patent_app_type] => utility [patent_app_number] => 13/870625 [patent_app_country] => US [patent_app_date] => 2013-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7271 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13870625 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/870625
GRAPHITE-COATED MAGNETIC NANOPARTICLES Apr 24, 2013 Abandoned
Array ( [id] => 15160823 [patent_doc_number] => 10485884 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-26 [patent_title] => RNA formulation for immunotherapy [patent_app_type] => utility [patent_app_number] => 14/388192 [patent_app_country] => US [patent_app_date] => 2013-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 27303 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388192 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/388192
RNA formulation for immunotherapy Mar 24, 2013 Issued
Array ( [id] => 9280351 [patent_doc_number] => 20140030319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'Antagonists Of The Oncongenic Activity Of The Protein MDM2, And Use Thereof In the Treatment of Cancers' [patent_app_type] => utility [patent_app_number] => 13/835524 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10640 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13835524 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/835524
Antagonists Of The Oncongenic Activity Of The Protein MDM2, And Use Thereof In the Treatment of Cancers Mar 14, 2013 Abandoned
Array ( [id] => 11342317 [patent_doc_number] => 09526702 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-27 [patent_title] => 'Vaccine nanotechnology' [patent_app_type] => utility [patent_app_number] => 13/844258 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 83 [patent_no_of_words] => 68750 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13844258 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/844258
Vaccine nanotechnology Mar 14, 2013 Issued
Array ( [id] => 10064117 [patent_doc_number] => 09102950 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-11 [patent_title] => 'Compositions and methods for enhancing immune responses to vaccines' [patent_app_type] => utility [patent_app_number] => 13/835806 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 26275 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13835806 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/835806
Compositions and methods for enhancing immune responses to vaccines Mar 14, 2013 Issued
Array ( [id] => 10911849 [patent_doc_number] => 20140314865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'Vaccine Nanotechnology' [patent_app_type] => utility [patent_app_number] => 13/844382 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 68736 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13844382 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/844382
Vaccine nanotechnology Mar 14, 2013 Issued
Array ( [id] => 11697651 [patent_doc_number] => 09687548 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-27 [patent_title] => 'Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 14/395210 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 16443 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14395210 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/395210
Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods of use thereof Mar 13, 2013 Issued
Array ( [id] => 9823512 [patent_doc_number] => 08932993 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-01-13 [patent_title] => 'Method of testing for endometriosis and treatment therefor' [patent_app_type] => utility [patent_app_number] => 13/788913 [patent_app_country] => US [patent_app_date] => 2013-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 41581 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13788913 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/788913
Method of testing for endometriosis and treatment therefor Mar 6, 2013 Issued
Array ( [id] => 9844212 [patent_doc_number] => 08946127 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms' [patent_app_type] => utility [patent_app_number] => 13/784121 [patent_app_country] => US [patent_app_date] => 2013-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 23 [patent_no_of_words] => 9623 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13784121 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/784121
Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms Mar 3, 2013 Issued
Array ( [id] => 9699518 [patent_doc_number] => 20140249203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'NANOPARTICLES STABILIZED WITH NITROPHENYLBORONIC ACID COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/782486 [patent_app_country] => US [patent_app_date] => 2013-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 32087 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13782486 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/782486
Nanoparticles stabilized with nitrophenylboronic acid compositions Feb 28, 2013 Issued
Array ( [id] => 11242654 [patent_doc_number] => 09468681 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-18 [patent_title] => 'Targeted nanoparticles' [patent_app_type] => utility [patent_app_number] => 13/782458 [patent_app_country] => US [patent_app_date] => 2013-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 33499 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13782458 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/782458
Targeted nanoparticles Feb 28, 2013 Issued
Array ( [id] => 9003136 [patent_doc_number] => 20130224261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'ENVIRONMENTALLY-RESPONSIVE NANOCOMPOSITES AND METHODS OF THEIR USE' [patent_app_type] => utility [patent_app_number] => 13/770943 [patent_app_country] => US [patent_app_date] => 2013-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 26612 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13770943 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/770943
ENVIRONMENTALLY-RESPONSIVE NANOCOMPOSITES AND METHODS OF THEIR USE Feb 18, 2013 Abandoned
Array ( [id] => 10627671 [patent_doc_number] => 09345810 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Liquefaction of bone matrix' [patent_app_type] => utility [patent_app_number] => 14/377272 [patent_app_country] => US [patent_app_date] => 2013-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16956 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14377272 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/377272
Liquefaction of bone matrix Feb 6, 2013 Issued
Menu